Ignite Creation Date:
2024-05-06 @ 4:51 PM
Last Modification Date:
2024-10-26 @ 2:17 PM
Study NCT ID:
NCT05116956
Status:
UNKNOWN
Last Update Posted:
2021-11-23
First Post:
2021-10-15
Brief Title:
SKin and Soft Tissue Necrotizing INfections in the Intensive Care Unit a Prospective Multi-national Cohort Study
Sponsor:
Henri Mondor University Hospital
Organization:
Henri Mondor University Hospital
Study Overview
Official Title:
SKin and Soft Tissue Necrotizing INfections in the Intensive Care Unit a Prospective Multi-national Cohort Study
Status:
UNKNOWN
Status Verified Date:
2021-11
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
SKIN-ICU
Brief Summary:
Necrotizing soft-tissue infections NSTI are rare and life-threatening bacterial infections characterized by subcutaneous tissue fascia or muscle necrosis Few prospective studies have been performed and our current knowledge on NSTI is mostly derived from retrospective single center studies The SKin and soft tissue necrotizing INfections in the ICU SKIN-ICU study is a multinational prospective non-interventional cohort study that will include patients admitted to the ICUintermediate care unit for NSTI or not
The objectives of the study are
1 To assess hospital ie ICU and hospital mortality and medium-term day-90 mortality functional outcomes and health-related quality of life scores HR-QoL outcomes
2 To report the clinical presentation and microbiological epidemiology of NSTI and identify independent prognostic factors of mortality and altered quality of life
The objectives of the study are
1 To assess hospital ie ICU and hospital mortality and medium-term day-90 mortality functional outcomes and health-related quality of life scores HR-QoL outcomes
2 To report the clinical presentation and microbiological epidemiology of NSTI and identify independent prognostic factors of mortality and altered quality of life
Detailed Description:
Necrotizing soft-tissue infections NSTI are rare and life-threatening bacterial infections characterized by subcutaneous tissue fascia or muscle necrosis The mortality of NSTIs is high ranging from 9 in non-selected patients to up to 30 in the most severe forms requiring intensive care unit ICU admission
With an incidence of 4100 000 persons per year initial misdiagnosis is frequent with no reliable diagnostic test available frequently leading to a delayed surgical debridement of infected tissues one of the main modifiable prognostic factors According to international recommendations any cutaneous infection associated with the failure of one or more organs or showing a dramatic deterioration must include the diagnosis of NSTI for consideration even if there is no local sign of the condition being severe The diagnosis is confirmed by identifying during surgery deficient tissue sometimes necrotic which comes away easily in the fingers and by the presence of the typical foul-smelling dishwasher exudate
The early management of NSTIs is challenging and requires a coordinated and multidisciplinary approach Treatment of NSTIs consists of early broad-spectrum antimicrobial therapy together with emergency and aggressive surgical debridement including excision of all necrotic and infected tissues Few prospective studies have been performed and our current knowledge on NSTI is mostly derived from retrospective single center studiesThe few randomized therapeutic trials testing interventions in this setting have been disappointing in part because of the difficulty to identify subgroups for individualized treatments A large international study aimed at collecting granular data on the clinical presentation microbiology management and outcomes of patients with NSTI admitted in the ICU and involving a large number of centers and countries is thus desirable to improve our knowledge on this devastating condition
The SKin and soft tissue INfections in the ICU SKIN-ICU study is a multinational prospective non-interventional cohort study that will include patients with NSTI admitted or not to the ICUintermediate care unit and aim at addressing the following points 1 Hospital ie ICU and hospital mortality and medium-term outcomes three- and six-month survival functional outcomes and health-related quality of life scores HR-QoL and 2 Clinical presentation and microbiological epidemiology of NSTI
With an incidence of 4100 000 persons per year initial misdiagnosis is frequent with no reliable diagnostic test available frequently leading to a delayed surgical debridement of infected tissues one of the main modifiable prognostic factors According to international recommendations any cutaneous infection associated with the failure of one or more organs or showing a dramatic deterioration must include the diagnosis of NSTI for consideration even if there is no local sign of the condition being severe The diagnosis is confirmed by identifying during surgery deficient tissue sometimes necrotic which comes away easily in the fingers and by the presence of the typical foul-smelling dishwasher exudate
The early management of NSTIs is challenging and requires a coordinated and multidisciplinary approach Treatment of NSTIs consists of early broad-spectrum antimicrobial therapy together with emergency and aggressive surgical debridement including excision of all necrotic and infected tissues Few prospective studies have been performed and our current knowledge on NSTI is mostly derived from retrospective single center studiesThe few randomized therapeutic trials testing interventions in this setting have been disappointing in part because of the difficulty to identify subgroups for individualized treatments A large international study aimed at collecting granular data on the clinical presentation microbiology management and outcomes of patients with NSTI admitted in the ICU and involving a large number of centers and countries is thus desirable to improve our knowledge on this devastating condition
The SKin and soft tissue INfections in the ICU SKIN-ICU study is a multinational prospective non-interventional cohort study that will include patients with NSTI admitted or not to the ICUintermediate care unit and aim at addressing the following points 1 Hospital ie ICU and hospital mortality and medium-term outcomes three- and six-month survival functional outcomes and health-related quality of life scores HR-QoL and 2 Clinical presentation and microbiological epidemiology of NSTI
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None